FRUQUINTINIB
Clinical trials for FRUQUINTINIB explained in plain language.
Never miss a new study
Get alerted when new FRUQUINTINIB trials appear
Sign up with your email to follow new studies for FRUQUINTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo targets lingering cancer cells in colorectal patients
Disease control Recruiting nowThis study tests whether two drugs, fruquintinib and tislelizumab, can control leftover cancer cells in people with colorectal cancer who have completed chemotherapy but still show signs of minimal residual disease (MRD) on a blood test. About 20 participants will receive the com…
Matched conditions: FRUQUINTINIB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:01 UTC
-
New drug cocktail shows promise for tough stomach cancer
Disease control Recruiting nowThis study is testing whether adding a drug called fruquintinib to standard chemotherapy and trastuzumab can help control advanced HER2-positive stomach or gastroesophageal junction cancer. It is for people who have not had prior treatment for their metastatic disease. The goal i…
Matched conditions: FRUQUINTINIB
Phase: PHASE1, PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 17, 2026 02:56 UTC
-
New hope: Chemo-Free cocktail targets advanced colorectal cancer
Disease control Recruiting nowThis study tests whether a combination of targeted drugs (cetuximab beta and fruquintinib), with or without immunotherapy, can control advanced colorectal cancer without chemotherapy. About 70 adults with a specific genetic type (RAS/BRAF wild-type) will receive these drugs as th…
Matched conditions: FRUQUINTINIB
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 14, 2026 12:02 UTC